Loss of CD5 expression has been reported in 43% of CD45+CD4+ T-cell lymphomas [25], whereas data concerning the expression of CD44 in different T-cell lymphoma subtypes are not available. This evidence concerns the gene CD4 and T-cell non-Hodgkin lymphoma.